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Purpose. Previous studies reported the relation of osteoarthritis (OA) and hypertension (HTN)mostly in postmenopausal women.
*is study aimed to identify the association between OA and HTN in pre- and postmenopausal women.Methods. We used data of
4,627 middle-aged (40–59 years) women from the Korea National Health and Nutrition Examination Survey (KNHANES) from
2012 to 2016. Chi-square and t-test compared the characteristics of the participants. Binomial logistic regression was used to
identify an association between OA and HTN under controlling covariates such as age, tobacco smoking, alcohol consumption,
and obesity. Results. *ere were 1,859 participants with non-OA and menopause, 104 with OA and nonmenopause, and 375 with
OA and menopause, respectively. *e number of women with OA and HTN was 129. OA was significantly associated with HTN
diagnosis in postmenopausal women under controlling covariates (odds ratio: 1.408, 95% CI: 1.092–1.815, p � 0.008). However,
this relationship was weakened in premenopausal women (odds ratio: 1.651, 95% CI: 0.950–2.869, p � 0.075). Conclusion. In
conclusion, women with HTN showed a distinct association with OA than the normotensives, and this relationship was more
apparent among postmenopausal women. Further research is needed for a preventive approach.
1. Introduction
At middle age in the life cycle, chronic diseases begin, but
preventive intervention is still applicable. *ere is a quali-
tative difference in middle-aged women’s health, depending
on whether they are menopause (Mp) because hormone
metabolism changes. As the circulating estrogen decreases,
the risk of HTN and cardiovascular disease increases [1], and
gender difference became remarkable in terms of the
deteriorated degenerative changes in the articular cartilage
[2]. *erefore, menopausal status in the two major chronic
diseases, HTN and osteoarthritis (OA), makes a funda-
mental difference.
OA, a highly prevalent disease in the elderly and severe
joint disease at the same time because of deterioration and
inflammation of the articular cartilage, has been known as
the major leading cause of disability with activity restriction
and pain resulting in low quality of life as well as a higher rate
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of hospitalization [3, 4]. Moreover, the aging population has
been reported to be exposed to painful disabling OA leading
to higher therapeutic costs [4–6]. In several previous pieces
of research, tobacco smoking, divorce, unemployment [7],
old age, sex, obesity, low educational level, low strength
exercise frequency, manual labor, and HTN [8, 9] were
reported as potential risk factors for OA [6–9].
HTN has been reported as a primary and most common
independent risk factor for cardiovascular disease, as well as
one of the metabolic syndrome components, and then as the
3rd major cause of disability worldwide [10, 11].
Association between high blood pressure and OA has
been reported [8, 9], but few studies have been conducted on
this topic. In a cross-sectional study of men and women over
50 years old, the risk of OA in patients with hypertension
was 1.394 times (95% CI: 1.052–1.846) [8]. In a community
survey for over 50, the prevalence of OA in women was three
times that of men, and hypertension was associated with
knee osteoarthritis [9]. Hart et al. suggested a significant
association between OA and metabolic syndrome, including
hyperglycemia and hyperlipidemia, based on an analysis
with women aged 45–64 [12]. *is result supports the hy-
pothesis that OA can be described as a metabolic factor in its
mechanism, as suggested by Velasques and Katz [13].
However, most of the above studies seem to include only
postmenopausal women. On the contrary, Inoue et al. [14]
studied community participants aged 30–86 years, and the
prevalence of hypertension in the OA group was higher in
both men and women, but the relationship with the met-
abolic syndrome was found only in women [14]. *ese
results suggest that the relationship between OA and HTN
was also raised in premenopausal women. However, we
could not find any analysis considering menopause in the
above studies.
Also, it has been challenging to find a study that explores
the relationship between hypertension and OA, considering
menopause, apart from metabolic syndrome in middle-aged
women rather than the elderly. In middle age, the number of
women diagnosed with hypertension increases. *erefore, if
there is a link to the risk of OA, then this is an appropriate
time to implement preventive behavior for joint protection.
Besides, in clinical practice, information about risks and
preventive skills according to each woman’s life cycle is
needed. So, it is necessary to find out the difference due to
the menopausal status.
*erefore, this study aims to identify the association
between OA and HTN with the population of middle age,
40–59 years, in pre- and postmenopausal women using the
Korea National Health and Nutrition Examination Survey
(KNHANES) data.
2. Methods
2.1. Study Population. *is cross-sectional study used the
Korea National Health and Nutrition Examination Survey
(KNHANES) from 2012 to 2016, performed by the Korea
Centers for Disease Control and Prevention (KCDC).
Kweon et al. described the details of the survey design and
data resource profile in 2014 [15]. KNHANES is nationwide
representative data using two-step stratified clustered equal-
probability sampling. As a first step, the population was
stratified into 16 administrative areas, and in the second
step, it was stratified into 26 substrata according to age and
sex in general residential areas. Investigation clusters were
selected from the strata, and about 20 households were
selected in each cluster. All family members of the house-
holds who were older than one year were invited into the
survey [15, 16]. *e institutional review board approved the
protocols of this study of the KCDC with obtaining written
informed consent forms from all participants. KNHANES
data from 2012 to 2016 included the survey on health in-
terviews, health examination, and nutritional assessment.
We selected female participants more than 40 years old and
less than 60 years old who completed the evaluations, such as
HTN diagnosis (yes or no), osteoarthritis diagnosis (yes or
no), and menopause (yes or no). A total of 4,627 female
participants were finally involved in the analysis.
2.2. Identification of Osteoarthritis and Menopause Status.
It was confirmed about OA diagnosis if participants have
been diagnosed with OA by physicians or not in health
survey questionnaires in KNHANES. We excluded the pa-
tients with no answer or nonapplicable in the questionnaire.
Menopause included both natural and artificial menopause.
Artificial menopause means menopause by bilateral ovarian
removal, and natural menopause means that normal men-
struation stopped for more than one year due to a decline in
ovarian function.
2.3. Characteristics of the Participants. *e following base-
line sociodemographic characteristics were assessed: age
with ≥40 years and <60 years, smoking status classified as
none, past, or current, alcohol consumption classified as
nondrinker + under one glass per month or over one glass
per month, menopause classified as yes or no, HTN diag-
nosis classified as yes or no, and BMI classified as low
(<18.5 Kg/m2), normal (18.5 to <25.0Kg/m2), or obesity
(25.0 or higher Kg/m2). Korean version of the euro quality of
life-5 dimensions (EQ-5D) is a composite measure of health
outcomes consisting of mobility, self-care, daily activity,
pain/discomfort, and anxiety/depression with each factor
containing three-level health status [17]. In laboratory data,
systolic blood pressure (SBP, mmHg), diastolic blood
pressure (DBP, mmHg), fasting blood sugar (FBS, mg/dL),
triglyceride (TG, mg/dL), cholesterol (Chol, mg/dL), high-
density lipoprotein cholesterol (HDL-C, mg/dL), aspartate
aminotransferase (AST, IU/L), alanine aminotransferase
(ALT, IU/L), and creatinine (CREA, mg/dL) were involved.
2.4. Statistical Analyses. *e data were expressed by num-
bers and percentages for describing the general character-
istics of the study participants, and the frequency in each
group (OA or non-OA, Mp or PreMp, and HTN or non-
HTN) was compared by the chi-square test. *e proportion
was estimated using weights and “survey” procedures
according to the analysis protocol provided by the Korean
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CDC, which accounted for the proportion of selection and
proportion of response [16]. An independent t-test was
performed to determine the difference between clinical
variables in each group. Binomial logistic regression was
used to identify an association between OA and HTN with
the participants aged 40–59, in total, PreMp and Mp women
by determining odds ratios (ORs) and 95% confidence in-
tervals (CIs), under controlling covariates such as age, to-
bacco smoking, alcohol consumption, and obesity as
categorical variables.*e significance level was less than 0.05
for p values. We used IBM SPSS Statistics 22.0 software
(IBM Corp, Armonk, NY).
3. Results
3.1. Characteristics of the Study Population. A total of 4,627
female participants were included in this study. Overall
mean age was 49.7 (5.8) years old, 49.2 (5.7) in 4148 non-OA
participants and 53.9 (4.3) in 479 OA participants. *ere
were 2,289 (55.2%) participants with non-OA and non-
menopause, 1859 (44.8%) with non-OA andmenopause, 104
(21.7%) with OA and nonmenopause, and 375 (78.3%) with
OA and menopause, respectively. In HTN diagnosis, 3,604
(86.9%) participants were with non-OA and non-HTN, 544
(13.1%) with non-OA and HTN, 350 (73.1%) with OA and
non-HTN, and 129 (26.9%) with OA and HTN, respectively.
Other results are shown in Table 1.
3.2. Characteristics of the Premenopause and Menopause
Groups according to the Osteoarthritis Status. In both non-
OA and OA groups, the Mp group had a significantly higher
age, more HTN, and less alcohol consumption than the
PreMp group. In the non-OA group, there were significantly
more nonsmokers in the Mp group (p � 0.042), and there
were also more obese subjects (p � 0.004), but these were
not significantly related with Mp in the OA group.
In both non-OA and OA groups, the Mp group had
significantly higher SBP and higher cholesterol than the
PreMp group. Mp subjects of the non-OA group showed
higher DBP, FBS, TG, AST, and ALT, but they had lower
HDL-C than the PreMp group. However, there was no
significant difference in these clinical laboratory variables
between PreMp and Mp subjects in the OA group. In both
non-OA and OA groups, creatinine was not associated with
the Mp status (Table 2).
3.3. Characteristics of the Groups with and without Hyper-
tension according to the Menopause Status. In both PreMp
group and Mp group, the HTN group showed significantly
Table 1: Characteristics of the groups with and without OA.
Characteristics Non-OA (n� 4,148)n (%)
OA (n� 479)
n (%)
Age (years) 40–49 2141 (51.6) 77 (16.1)50–59 2007 (48.4) 402 (83.9)
Smoking
Smoking 208 (5.0) 29 (6.1)
Past 142 (3.4) 26 (5.5)
Nonsmoking 3781 (91.5) 421 (88.4)
Alcohol consumption
No 538 (13.0) 65 (13.7)
<1/ma 1772 (42.9) 215 (45.1)
>1/ma 1823 (44.1) 196 (41.2)
Menopause No 2289 (55.2) 104 (21.7)Yes 1859 (44.8) 375 (78.3)
Hypertension No 3604 (86.9) 350 (73.1)Yes 544 (13.1) 129 (26.9)
BMI (Kg/m2)
Low (<18.5) 138 (3.3) 8 (1.7)
Normal (18.5 to <25) 2884 (69.6) 242 (50.5)
Obesity (≥25) 1119 (27.0) 229 (47.8)
Clinical
Mean (SD) Mean (SD)
Age (years) 49.2 (5.7) 53.9 (4.3)
EQ-5D 1.0 (0.1) 0.9 (0.1)
SBP (mmHg) 114.7 (15.9) 119.3 (17.0)
DBP (mmHg) 75.2 (9.7) 77.1 (10.1)
FBS (mg/dL) 97.8 (21.6) 101.0 (27.5)
TG (mg/dL) 118.7 (91.7) 134.3 (88.4)
Chol (mg/dL) 197.0 (35.0) 204.3 (38.1)
HDL-C (mg/dL) 54.6 (12.4) 53.7 (13.4)
AST (IU/L) 21.0 (10.0) 23.0 (16.1)
ALT (IU/L) 18.8 (14.7) 21.3 (15.9)
CREA (mg/dL) 0.7 (0.2) 0.7 (0.1)
SD: standard deviation; OA: osteoarthritis; EQ-5D: euro quality of life-5 dimensions; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBS: fasting
blood sugar; TG: triglyceride; Chol: cholesterol; HDL-C: high-density lipoprotein cholesterol; AST: aspartate aminotransferase; ALT: alanine amino-
transferase; CREA: creatinine. a1/m� 1 glass per month.
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higher age, more OA, and more obesity cases. Smoking and
alcohol consumption status were not associated with HTN
in both groups.
In both PreMp group and Mp group, HTN patients had
significantly higher SBP (p< 0.001), DBP (p< 0.001), FBS
(p< 0.001), TG (p< 0.001), AST, ALT, and lower HDL-C
(p< 0.001). HTN patients of the Mp group showed lower
cholesterol than nonhypertensive subjects, but there was no
significant difference in cholesterol according to HTN in the
PreMp group (Table 3).
3.4. Association between OA and HTN according to the
Menopause Status. *e association between OA and HTN in
the Mp status is shown in Table 4. In the results of binomial
logistic regression, it was found that OA diagnosed by a
physician was associated with HTN diagnosis in the total
participants aged 40–59 women with and without controlling
covariates (OR� 2.442, 95% CI: 1.957–3.046, p< 0.001;
OR� 1.376, 95% CI: 1.083–1.747, p � 0.009, respectively).
*e OA diagnosis showed a significant association with
HTN diagnosed by physicians in which the OR of HTN was
2.939 (95% CI: 1.744–4.954, p< 0.001) in PreMp and 1.594
(95% CI: 1.243–2.045, p< 0.001) in Mp without controlling
covariates. In adjusting for covariates, OA was identified as
having a significant association with HTN in Mp partici-
pants, which showed OR 1.408 (95% CI: 1.092–1.815,
p � 0.008) in the participants with Mp. However, in PreMp
participants, the association between OA and HTN was
weakened (OR� 1.651, 95% CI: 0.950–2.869, p � 0.075).
4. Discussion
*is study demonstrated that OA diagnosed by a physician
was significantly associated with HTN diagnosis in middle-
aged women (range: 40–59 years) after adjustment for age,
smoking, alcohol, and obesity, although the association was
weak in premenopausal women.
Several studies described the association between OA
and metabolic syndrome [8, 18–20]. Among the results on
metabolic syndrome, Lee et al. reported that HTN patients
showed a significantly higher prevalence of knee OA in the
Korean population. Hart et al. also found that HTN is one of
the metabolic factors associated with knee OA [8, 12].
Puenpatom and Victor found that HTN, abdominal obesity,
and hyperglycemia were more prevalent in patients with OA
than in those without OA [21]. HTN is possible to be an
independent risk factor for knee OA. However, because


















Age (years) 40–49 2141 1943 (84.9) 198 (10.7) <0.001 77 65 (62.5) 12 (3.2) <0.00150–59 2007 346 (15.1) 1661 (89.3) 402 39 (37.5) 363 (96.8)
Smoking
Smoking 208 116 (5.1) 92 (5.0)
0.042
29 8 (7.8) 21 (5.6)
0.705Past 142 93 (4.1) 49 (2.6) 26 6 (5.8) 20 (5.4)
Nonsmoking 3781 2072 (90.8) 1709 (92.4) 421 89 (86.4) 332 (89.0.)
Alcohol
consumption
No 538 232 (10.2) 306 (16.5)
<0.001
65 8 (7.8) 57 (15.3)
0.040<1/ma 1772 934 (40.9) 838 (45.3) 215 43 (41.7) 172 (46.1)
>1/ma 1823 1116 (48.9) 707 (38.2) 196 52 (50.5) 144 (38.6)
HTN No 3604 2129 (93.0) 1475 (79.3) <0.001 350 85 (81.7) 265 (70.7) 0.015Yes 544 160 (7.0) 384 (20.7) 129 19 (18.3) 110 (29.3)
BMI (Kg/m2)
Low (<18.5) 138 93 (4.1) 45 (2.4)
0.004
8 3 (2.9) 5 (1.3)
0.217Normal (18.5 to<25) 2884 1602 (70.0) 1282 (69.1) 242 58 (55.8) 184 (49.1)
Obesity (≥25) 1119 592 (25.9) 527 (28.4) 229 43 (41.3) 186 (49.6)
Clinical
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age 4148 45.4 (3.9) 54.1 (3.6) <0.001 479 48.1 (3.9) 55.5 (2.8) <0.001
EQ-5D 4146 1.0 (0.1) 1.0 (0.1) <0.001 479 0.9 (0.1) 0.9 (0.1) 0.482
SBP (mmHg) 4140 111.9 (14.8) 118.0 (16.6) <0.001 478 114.8 (14.0) 120.6 (17.6) 0.002
DBP (mmHg) 4140 74.3 (9.7) 76.2 (9.6) <0.001 478 75.6 (9.7) 77.5 (10.2) 0.088
FBS (mg/dL) 3981 96.0 (18.8) 100.0 (24.5) <0.001 453 97.2 (20.9) 102.1 (29.0) 0.117
TG (mg/dL) 3982 109.0 (77.0) 130.7 (106.0) <0.001 453 125.8 (91.0) 136.8 (87.6) 0.274
Chol (mg/dL) 3982 191.2 (32.5) 204.3 (36.5) <0.001 453 197.6 (37.1) 206.2 (38.7) 0.046
HDL-C (mg/dL) 3982 55.4 (12.5) 53.7(12.3) <0.001 453 55.1 (13.2) 53.4(13.5) 0.250
AST (IU/L) 3982 19.4 (9.4) 23.0 (10.4) <0.001 453 20.9 (6.9) 23.6 (17.9) 0.143
ALT (IU/L) 3982 16.9 (15.0) 21.1 (14.1) <0.001 453 19.6 (11.6) 21.7 (16.9) 0.226
CREA (mg/dL) 3976 0.7 (0.1) 0.7 (0.2) 0.185 452 0.7 (0.1) 0.7 (0.1) 0.380
OA: osteoarthritis; Mp: menopause; HTN: hypertension; SD: standard deviation; EQ-5D: euro quality of life-5 dimensions; SBP: systolic blood pressure; DBP:
diastolic blood pressure; FBS: fasting blood sugar; TG: triglyceride; Chol: cholesterol; HDL-C: high-density lipoprotein cholesterol; AST: aspartate ami-
notransferase; ALT: alanine aminotransferase; CREA: creatinine. a1/m� 1 glass per month.
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HTN has been known to be related to many confounding
factors, it is still controversial that OA is associated with
HTN [9, 14].
*ese associations have been explained by mechanisms
such as inflammation, lipid metabolism, cytokines, and
vitamin D receptor. OA and metabolic syndrome were re-
ported to share the same mechanisms of inflammation.
Metabolic syndrome has been known as a factor leading to
the chronic low-grade inflammatory status in joint tissues.
Additionally, as cholesterol accumulated in the cartilage, the
efflux function of cartilage could be impaired, hence
inducing OA [22, 23]. Some studies suggested several shared
risk factors, such as aging, obesity, and chronic inflamma-
tion, implicated in the plausible mechanisms of the asso-
ciation between HTN and OA, and there are also several
reports that the proinflammatory cytokine interleukin-6 has
a vital role in HTN and knee OA [11, 24–28]. Additionally, it
was shown that polymorphisms in the vitamin D receptor
would be possible to be associated with low bone mineral
density, OA, and HTN [29, 30].
OA is a serious threat to women’s health. *e rates of
cartilage loss and progression of cartilage defects at the knee


















Age (years) 40–49 2018 1900 (94.2) 118 (5.8) <0.001 200 174 (87.0) 26 (13.0) <0.00150–59 390 328 (84.1) 62 (15.9) 2019 1552 (76.9) 467 (23.1)
Smoking
Smoking 124 112 (90.3) 12 (9.7)
0.613
113 86 (76.1) 27 (23.9)
0.801Past 99 92 (92.9) 7 (7.1) 69 52 (75.4) 17 (24.6)
Nonsmoking 2176 2017 (92.7) 159 (7.3) 2026 1579 (77.9) 447 (22.1)
Alcohol
consumption
No 378 349 (92.3) 29 (7.7)
0.574
434 335 (77.2) 99 (22.8)
0.097<1/ma 903 837 (92.7) 66 (7.3) 835 673 (80.6) 162 (19.4)
>1/ma 877 822 (93.7) 55 (6.3) 580 441 (76.0) 139 (24.0)
OA No 2303 2142 (93.0) 161 (7.0) <0.001 1845 1462 (79.2) 383 (20.8) <0.001Yes 105 86 (81.9) 19 (18.1) 374 264 (70.6) 110 (29.4)
BMI (Kg/m2)
Low (<18.5) 96 95 (99.0) 1 (1.0)
<0.001
50 49 (98.0) 1 (2.0)
<0.001Normal (18.5 to<25) 1668 1578 (94.6) 90 (5.4) 1458 1228 (84.2) 230 (15.8)
Obesity (≥25) 639 550 (86.1) 89 (13.9) 709 447 (63.0) 262 (37.0)
Clinical
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age 2408 45.3 (3.7) 47.8 (3.8) <0.001 2219 54.1 (3.6) 55.2 (3.1) <0.001
EQ-5D 2406 1.0 (0.1) 1.0 (0.1) 0.054 2219 0.9 (0.1) 0.9 (0.1) 0.018
SBP (mmHg) 2401 111.0 (14.4) 124.3 (14.4) <0.001 2217 115.7 (15.7) 128.4 (16.6) <0.001
DBP (mmHg) 2401 73.7 (9.5) 81.8 (9.9) <0.001 2217 75.2 (9.3) 81.2 (9.9) <0.001
FBS (mg/dL) 2316 95.3 (17.7) 104.6 (28.0) <0.001 2118 98.6 (21.6) 106.9 (35.0) <0.001
TG (mg/dL) 2317 106.7 (74.2) 146.9(104.4) <0.001 2118 126.1 (87.7)
152.2
(144.8) <0.001
Chol (mg/dL) 2317 191.2 (32.3) 194.1 (37.1) 0.325 2118 207.3 (36.4) 195.4 (37.0) <0.001
HDL-C (mg/dL) 2317 55.7 (12.5) 51.5 (11.8) <0.001 2118 54.4 (12.6) 51.1 (12.0) <0.001
AST (IU/L) 2317 19.2 (8.6) 22.7 (15.2) 0.003 2118 22.6 (9.4) 25.0 (18.5) 0.006
ALT (IU/L) 2317 16.5 (13.8) 23.3 (22.8) <0.001 2118 20.2 (13.0) 24.7 (18.9) <0.001
CREA (mg/dL) 2317 0.7 (0.1) 0.7 (0.2) 0.144 2118 0.7 (0.1) 0.7 (0.4) <0.001
OA: osteoarthritis; Mp: menopause; HTN: hypertension; SD: standard deviation; EQ-5D: euro quality of life-5 dimensions; SBP: systolic blood pressure; DBP:
diastolic blood pressure; FBS: fasting blood sugar; TG: triglyceride; Chol: cholesterol; HDL-C: high-density lipoprotein cholesterol; AST: aspartate ami-
notransferase; ALT: alanine aminotransferase; CREA: creatinine. a1/m� 1 glass per month.
Table 4: Association between hypertension and osteoarthritis among total, premenopause, and menopause groups from logistic regression
analysis.
Unadjusted OR p value Adjusteda OR p value
Total Non-HTN 1.000 — 1.000 —HTN 2.442 (1.957, 3.046) <0.001 1.376 (1.083, 1.747) 0.009
PreMp (n� 2,408) Non-HTN 1.000 — 1.000 —HTN 2.939 (1.744, 4.954) <0.001 1.651 (0.950, 2.869) 0.075
Mp (n� 2,219) Non-HTN 1.000 — 1.000 —HTN 1.594 (1.243, 2.045) <0.001 1.408 (1.092, 1.815) 0.008
aAdjusted for age, smoking, alcohol consumption, and BMI (continuous variable). OR: odds ratio; Mp: menopause; HTN: hypertension.
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have been increased in women more than in men [2].
Moreover, this study reported the results of distinguishing
between menopause because OA appears differently
depending on the menopause status. Mahajan and Patni
reported that menopause is associated with the onset and
progression of OA in women, and hand OA was more
common in postmenopausal women, even if an important
covariate, the age, was controlled [31, 32]. Magliano reported
41% of perimenopausal women had joint pain and stiffness
in comparison with 25% of premenopausal women even
though the significance was borderline in controlling age.
Menopause is also associated with HTN. Cutler et al. re-
ported that women with menopause could have a high
prevalence of HTN regardless of their ethnicity [33], though
it has not been conclusive to be an independent risk factor
for HTN [34].
It was difficult to find studies on the association between
OA andHTN based on themenopause status inmiddle-aged
women. *e authors emphasize the importance of timely
intervention of a preventive approach for skeletal joint
protection. To this end, studies for middle-aged, premen-
opausal women are needed, but they have not been con-
ducted sufficiently.*is study reported that a modest change
was already underway in premenopausal women, suggesting
the necessity for more active research for the middle-aged
population, although their change seems to be just
beginning.
*e results are similar to the positive relation of met-
abolic syndrome and radiographic knee OA in the Japanese
study, including middle-aged women, conducted by Inoue
et al. [14]. *ey showed a significant association, and those
strong results may be due to the precise diagnosis of OA
through radiography. Age, smoking, drinking, and fitness
habit were adjusted in their logistic regression model, but all
of the four covariates were not significant. In our analytical
model, age, smoking, and drinking were included according
to the precedent of this most similar study [14]. Obesity was
also included in the model instead of fitness habit because of
the strong positive association with knee OA (OR: 1.563;
95% CI: 1.191–2.051) reported in Lee et al.’s study [8].
OA, HTN, and menopause status, these three conditions
have shared risk factors such as age, obesity, and sex [22].
However, a comprehensive study investigating the associ-
ation among these conditions was scarce. *is study is
unique in this part. Another strength of our research is the
representativeness of the study sample, which is possible to
provide credence to the result validity. Also, several con-
founders were controlled in our analysis to guarantee the
robustness of the results.
*ere are several limitations to interpreting the results of
this study. Firstly, it was impossible to demonstrate any
causal relationship between OA andHTN in women because
this study had a cross-sectional design. Secondly, it was not
able to adjust whether the patients with OA and HTN di-
agnosed by the physician were on treatment or not due to
data limitation. *ere was no consideration that it was
surgical menopause or natural menopause, and it was not
known whether hormone replacement therapy or any
treatment for menopausal symptoms was performed. Also,
the location of OA, such as the knee, lumber, or hand, was
not clear. Another limitation is the lack of uric acid in-
formation. Uric acid has been introduced as an inflam-
matory marker for cardiovascular diseases and metabolic
syndrome. Besides, hyperuricemia can induce gout ar-
thropathy, which might be confused with osteoarthritis [35].
*erefore, information on uric acid would be helpful to
clarify the results of this article. However, uric acid could not
be used because it was not obtained from that year’s data. In
the future, it would be needed to perform a more com-
prehensive study to overcome these limitations.
5. Conclusion
To our knowledge, this is the first report that explored the
association between OA diagnosis and HTN according to
the menopausal status, including the premenopausal group.
As a result, middle-aged women with HTN have higher risk
for OA than the normotensives, and this association was
more apparent among postmenopausal women.
In further study, more clear explanations of these
mechanisms are needed, including prospective research, to
assess a causal association between OA and HTN to develop
preventive strategies for women in middle age to achieve
active life in their elderly.
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